Global Erlotinib Hydrochloride Market Status and Outlook 2018-2025

July 2018 | 251 pages | ID: G021E208E62EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Roche
• Cipla
• Mylan
• Teva
• OSI Pharmaceuticals
• Glenmark Pharmaceuticals
• Beacon Pharmaceuticals
• Raichem Lifesciences
• United Biotech
• CJ Corporation
• Vivimed Labs
• Boryung Pharmaceutical
• Taj Pharmaceuticals
• Pharmascience
• Natco Pharma
• Intas Pharmaceuticals
• RPG Life Sciences
• Pharmascience
• Schwarz Pharma
• Dr. Reddy's Laboratories
• Glenmark Pharmaceuticals
• Chugai Pharmaceutical
• DKSH
• Firma Chun Cheong
• Kremers Urban Pharmaceuticals
• Ortat
• Zuellig Pharma

Market by Type

• 25mg
• 100mg
• 150mg

Market by Application

• Non-small Cell Lung Cancer
• Pancreatic Cancer

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Erlotinib Hydrochloride Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 25mg
  3.1.2 100mg
  3.1.3 150mg
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Non-small Cell Lung Cancer
  4.1.2 Pancreatic Cancer
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 25mg Production by Region
    6.1.1.2 100mg Production by Region
    6.1.1.3 150mg Production by Region
  6.1.2 Production by Application
    6.1.2.1 Non-small Cell Lung Cancer Production by Region
    6.1.2.2 Pancreatic Cancer Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 25mg Demand by Region
    6.2.1.2 100mg Demand by Region
    6.2.1.3 150mg Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Non-small Cell Lung Cancer Demand by Region
    6.2.2.2 Pancreatic Cancer Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Roche
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Cipla
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Mylan
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Teva
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 OSI Pharmaceuticals
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Glenmark Pharmaceuticals
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Beacon Pharmaceuticals
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Raichem Lifesciences
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 United Biotech
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 CJ Corporation
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Vivimed Labs
8.12 Boryung Pharmaceutical
8.13 Taj Pharmaceuticals
8.14 Pharmascience
8.15 Natco Pharma
8.16 Intas Pharmaceuticals
8.17 RPG Life Sciences
8.18 Pharmascience
8.19 Schwarz Pharma
8.20 Dr. Reddy's Laboratories
8.21 Glenmark Pharmaceuticals
8.22 Chugai Pharmaceutical
8.23 DKSH
8.24 Firma Chun Cheong
8.25 Kremers Urban Pharmaceuticals
8.26 Ortat
8.27 Zuellig Pharma

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Erlotinib Hydrochloride Industry Dynamics & Regulations List
Table Global Erlotinib Hydrochloride Sales Revenue, Cost and Margin, 2015-2018E
Table Global Erlotinib Hydrochloride Market Status by Type 2015-2018E, in USD Million
Table Global Erlotinib Hydrochloride Market Status by Application 2015-2018E, in USD Million
Table Global Erlotinib Hydrochloride Market Status by Application 2015-2018E, in Volume
Table Global Erlotinib Hydrochloride Market by Region 2015-2018E, in USD Million
Table Global Erlotinib Hydrochloride Market Share by Region in 2018, in USD Million
Table Global Erlotinib Hydrochloride Market by Region 2015-2018E, in Volume
Table Global Erlotinib Hydrochloride Market Share by Region in 2018, in Volume
Table 25mg Production Value by Region 2015-2018E, in USD Million
Table 25mg Production Volume by Region 2015-2018E, in Volume
Table 100mg Production Value by Region 2015-2018E, in USD Million
Table 100mg Production Volume by Region 2015-2018E, in Volume
Table 150mg Production Value by Region 2015-2018E, in USD Million
Table 150mg Production Volume by Region 2015-2018E, in Volume
Table Non-small Cell Lung Cancer Production Value by Region 2015-2018E, in USD Million
Table Non-small Cell Lung Cancer Production Volume by Region 2015-2018E, in Volume
Table Pancreatic Cancer Production Value by Region 2015-2018E, in USD Million
Table Pancreatic Cancer Production Volume by Region 2015-2018E, in Volume
Table 25mg Market Size by Region 2015-2018E, in USD Million
Table 25mg Market Size by Region 2015-2018E, in Volume
Table 100mg Market Size by Region 2015-2018E, in USD Million
Table 100mg Market Size by Region 2015-2018E, in Volume
Table 150mg Market Size by Region 2015-2018E, in USD Million
Table 150mg Market Size by Region 2015-2018E, in Volume
Table Non-small Cell Lung Cancer Market Size by Region 2015-2018E, in USD Million
Table Non-small Cell Lung Cancer Market Size by Region 2015-2018E, in Volume
Table Pancreatic Cancer Market Size by Region 2015-2018E, in USD Million
Table Pancreatic Cancer Market Size by Region 2015-2018E, in Volume
Table GlobalErlotinib Hydrochloride Forecast by Type 2019F-2025F, in USD Million
Table Erlotinib Hydrochloride Forecast by Type 2019F-2025F, in Volume
Table Erlotinib Hydrochloride Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Erlotinib Hydrochloride Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Erlotinib Hydrochloride Market Forecast by Region 2019F-2025F, in USD Million
Table Erlotinib Hydrochloride Market Forecast by Region 2019F-2025F, in Volume
Table Roche Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Roche
Table Cipla Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Cipla
Table Mylan Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Mylan
Table Teva Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Teva
Table OSI Pharmaceuticals Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of OSI Pharmaceuticals
Table Glenmark Pharmaceuticals Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Glenmark Pharmaceuticals
Table Beacon Pharmaceuticals Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Beacon Pharmaceuticals
Table Raichem Lifesciences Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Raichem Lifesciences
Table United Biotech Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of United Biotech
Table CJ Corporation Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of CJ Corporation
Table Vivimed Labs Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Vivimed Labs
Table Boryung Pharmaceutical Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Boryung Pharmaceutical
Table Taj Pharmaceuticals Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Taj Pharmaceuticals
Table Pharmascience Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Pharmascience
Table Natco Pharma Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Natco Pharma
Table Intas Pharmaceuticals Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Intas Pharmaceuticals
Table RPG Life Sciences Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of RPG Life Sciences
Table Pharmascience Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Pharmascience
Table Schwarz Pharma Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Schwarz Pharma
Table Dr. Reddy's Laboratories Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Dr. Reddy's Laboratories
Table Glenmark Pharmaceuticals Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Glenmark Pharmaceuticals
Table Chugai Pharmaceutical Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Chugai Pharmaceutical
Table DKSH Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of DKSH
Table Firma Chun Cheong Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Firma Chun Cheong
Table Kremers Urban Pharmaceuticals Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Kremers Urban Pharmaceuticals
Table Ortat Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Ortat
Table Zuellig Pharma Information
Table Erlotinib Hydrochloride Sales, Cost, Margin of Zuellig Pharma
Table Global Erlotinib Hydrochloride Sales Revenue by Company 2015-2017, in USD Million
Table Global Erlotinib Hydrochloride Sales Volume by Company 2015-2017, in Volume
Table Global Erlotinib Hydrochloride Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Erlotinib Hydrochloride Picture
Figure Erlotinib Hydrochloride Industry Chain Diagram
Figure Global Erlotinib Hydrochloride Sales Revenue 2015-2018E, in USD Million
Figure Global Erlotinib Hydrochloride Sales Volume 2015-2018E, in Volume
Figure Global Erlotinib Hydrochloride Market Status by Type 2015-2018E, in Volume
Figure North America Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in USD Million
Figure North America Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in Volume
Figure Europe Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in USD Million
Figure Europe Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in Volume
Figure South America Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in USD Million
Figure South America Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in Volume
Figure Middle East Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in Volume
Figure Africa Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in USD Million
Figure Africa Erlotinib Hydrochloride Market Size and Growth 2015-2018E, in Volume
Figure Global Erlotinib Hydrochloride Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Erlotinib Hydrochloride Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Erlotinib Hydrochloride Sales Price Forecast 2019F-2025F
Figure Global Erlotinib Hydrochloride Gross Margin Forecast 2019F-2025F
Figure Global Erlotinib Hydrochloride Sales Revenue by Company in 2018, in USD Million
Figure Global Erlotinib Hydrochloride Price by Company in 2018
Figure Global Erlotinib Hydrochloride Gross Margin by Company in 2018